Prostate Cancer Care Disparity Analysis Project (ProGAP)
Launched by ANKARA UNIVERSITY · Sep 21, 2024
Trial Information
Current as of April 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Prostate Cancer Care Disparity Analysis Project (ProGAP) is an international study aimed at understanding how prostate cancer care varies around the world. Researchers want to find out if patients receive the same quality of treatment, regardless of where they live. To do this, they will survey doctors who specialize in treating prostate cancer from countries with varying income levels—ranging from low-income to high-income nations. The survey consists of 17 questions designed to gather information about the standards of care for prostate cancer in different regions.
Currently, the study is not yet recruiting participants, but it is looking for doctors such as urologists, medical oncologists, and radiation oncologists who directly care for prostate cancer patients. If eligible, these specialists will complete the online survey to help shed light on how care for prostate cancer can differ globally. Understanding these disparities is crucial for improving treatment and ensuring that all patients have access to the best possible care, regardless of their location.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Urologists, Uro-oncologists, Medical oncologists, Radiation oncologists
- Exclusion Criteria:
- • Non-clinical healthcare professionals Healthcare professionals not directly involved in the care of prostate cancer patients, Healthcare professionals with missing or incorrect email addresses
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Yüksel Ürün
Study Director
Ankara University
Deborah Mukherji
Study Director
Clemenceau Medical Center Hospital Dubai
Mohammed Shahait
Study Director
Al Zahra Hospital Dubai
Luis Castelo Branco
Study Director
IOSI Oncologist Institute of Southern Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported